Tiagabine Hydrochloride Tablet shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting 2026-04-15 · last update 2026-04-15
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/15/2026 Updated 04/15/2026 Discontinued 04/15/2026 |
| Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/15/2026 Updated 04/15/2026 Discontinued 04/15/2026 |
| Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/15/2026 Updated 04/15/2026 Discontinued 04/15/2026 |
| Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/15/2026 Updated 04/15/2026 Discontinued 04/15/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)